Global Single Use Bioreactor Market to is Growing at a CAGR of 18.37% Due to Growing Biotechnology Industry

Global single use bioreactor market is witnessing robust growth with double digit CAGR under the influence of technological advancements and clinical advantages over traditional bioreactors.

According to the Markets and Data Research report, “Global Single Use Bioreactor Market Assessment, Opportunities and Forecast, 2018-2032F”, Global Single Use Bioreactor market was estimated at USD 4,225.72 million in 2024 and is anticipated to reach USD 16,025.94 million by 2032, growing at a CAGR of 18.37% during the forecast period. The market for single-use bioreactors is driven by various key drivers and shaped by a variety of factors influencing its uptake and development. The major driver is the increasing need for biopharmaceuticals, such as monoclonal antibodies, cell and gene therapies, and biosimilars, that demand flexible, scalable, and efficient manufacturing. Single-use systems provide some unique benefits over conventional stainless-steel bioreactors, including lower risk of cross-contamination, less cleaning and validation demands, and shorter turnaround times between batches of production. These advantages make single-use bioreactors especially appealing to contract development and manufacturing organizations (CDMOs), contract manufacturing organizations (CMOs), and small-to-medium-sized companies, which typically handle multiple projects with different process requirements. Technical progress in single-use technology and bioreactor design also assists market expansion by allowing improved process control, scalability, and integration into contemporary bioprocessing pipelines. Regulatory forces demanding improved safety and compliance also promote the use of SUBs since they make it easy to comply with rigorous cGMP regulations through the reduction of risks of contamination. But the market is challenged by amongst others, higher production costs in the initial stages compared to stainless-steel systems, extractables and leachable concerns from disposable components, standardization and consistency of supply from manufacturers, concerns for sterility and performance consistency, environmental issues with plastic waste, as well as for better sterility and performance consistency. In spite of these challenges, steady innovation and growing investment in biotechnology facilities continue to present tremendous opportunities for the widespread adoption of single-use bioreactors in biopharmaceutical production.

Spread through 404 pages, the " Global Single Use Bioreactor Market" report includes an in-depth TOC, many market data figures, latest market developments, key drivers and opportunities, and a thorough study of major company profiles. Moreover, the report offers strategic recommendations, pricing analysis, market share analysis, and value chain analysis in detail.

Click Here To Get Complete Details: https://www.marketsandata.com/industry-reports/single-use-bioreactors-market

Key Takeaways:

• The biopharmaceutical production industry is rapidly adopting single-use bioreactors because of their various merits compared to traditional systems. Some of the merits include shorter changeover time between batches of production, limited risk of cross-contamination, and lower initial investment costs.
• Single-use bioreactors are predominantly applied in biopharmaceutical manufacturing, although their applications extend to other industries such as food and beverage, agriculture, and environmental science.
• Single-use bioreactors are encouraging more sustainable biomanufacturing processes, meeting the increasing demand for sustainability. They reduce waste, save energy by minimizing water and chemical usage, and eliminate cleaning and sterilization requirements.
• Continued technological advancements will continue to enhance the efficiency and reliability of single-use bioreactors. Future developments like advanced real-time monitoring sensors, artificial intelligence (AI), machine learning (ML), 3D printing, and Internet of Things (IoT) integration are expected to be integrated.

Global Single Use Bioreactor market is segmented in the following categories:

By Product: Single-use Bioreactor Systems, Single-use Media Bags, Single-use Filtration Assemblies and Accessories

By Type of Module: Stirred-Tank SUBs, Wave-Induced SUBs, Bubble-Column SUBs, Other

By Cell Type: Mammalian Cells, Bacterial Cells, Yeast Cells, Other

By Application: Bioproduction, Process Development, Research and Development

By End-user: Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, Academic and Research Institutes

By Region: North America, Europe, South America, Asia-Pacific, Middle East and Africa

Based on product, the single-use bioreactor systems category has the largest market share of the global market for single-use bioreactors. Single-use bioreactor systems are most often employed in biopharmaceutical manufacturing processes where a large yield of the product is required. The versatility, cost-effectiveness, and ability of single-use bioreactors to offer large-scale mass production would trigger demand from customers and drive the sector's strong growth. The demand for accelerated discovery and higher production of new bio-therapeutics, e.g., vaccines, antibodies, enzymes, and hormones, and growth in the product amounts that these bioreactors can produce are anticipated to propel the market growth.

Based on type of module, stirred-tank single-use bioreactors are most common due to their great mixing and oxygen transfer, which are required for good cell growth and product yield. Their established design fundamentals make them easy to scale from the laboratory to production size and make process development and technology transfer easy. Stirred-tank SUBs also promote flexibility, decreased cleaning and validation, lower capital cost, and fast changeover between batches, all of which improve manufacturing efficiency and flexibility in biopharmaceutical manufacturing.

Based on cell type, as a result of the excessive dependency of most biologics such as cell-based therapies, mAbs and vaccines on mammalian cell culture, biopharma companies are scaling up single-use cell culture plants, thus mammalian cells segment dominates. Growth is driven by the rapid adoption of mammalian cell lines, an increased focus on personalized medicine, and advancements in single-use perfusion technology. Single-use mammalian cell bioproduction is gaining prominence because regulatory bodies are certifying it for GMP manufacture.

Based on application, bioproduction and based on end-user, pharmaceutical and biotechnology companies segment dominate the market owing to rising demand of biologic drugs and subsequent dependency on bioproduction process for the same.

The North America region dominates the market led by the dominant presence of top biopharmaceutical firms, extensive adoption of cutting-edge bioprocessing technologies, and a well-established regulatory environment. The United States dominates the region with significant investment in biologics, biosimilars, and cell and gene therapy manufacturing. Increased contributions of CDMOs and biopharma expansions in Canada and Mexico are also driving market growth. In addition, supportive government policies, growth in R&D expenditure, and the swift transition towards flexible and scalable single-use manufacturing consolidate North America's leadership position in the world market.

Download Free Sample Report

Major Companies Operating in Global Single Use Bioreactor Market Include:

• Sartorious AG
• Danaher Corporation
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Getinge AB
• Eppendorf AG
• Entegris Inc
• Avantor Inc
• Celltainer Biotech BV
• Cellexus Ltd

Companies in the global single use bioreactor market are actively involved in research and development (R&D) initiatives to promote innovation, improve current technologies, and create new solutions.

In April 2025, Thermo Fisher Scientific Inc., a world leader in scientific services, has launched the 5L DynaDrive Single-Use Bioreactor, which has been designed to meet the evolving needs of modern bioprocessing. The new 5-liter bioreactor extends Thermo Fisher's comprehensive lineup of bioreactors with seamless integration from 1 to 5,000 liters. It is intended to accelerate process development at the bench scale and simplify the transition from laboratory to commercial production by using consistent reactor design and film materials in all sizes, enabling cost-effective and efficient scale-up.

“Global Single Use Bioreactor Market Assessment, 2018-2032F”, evaluates the future growth potential of global single use bioreactor market and provides statistics and information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision-makers to take investment decisions for their organizations more strategically. Moreover, the report identifies and examines the emerging trends along with key drivers, challenges, and opportunities in Global Single Use Bioreactor market.

Contact

Mr. Vivek Gupta

5741 Cleveland street,

Suite 120, VA beach, VA, USA 23462

Tel: +1 (757) 343-3258

Email: info@marketsandata.com

Website: https://www.marketsandata.com